Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : NEOTHERAPEUTICS (NEOT) (NEOTW) -- Ignore unavailable to you. Want to Upgrade?

To: David M. Evans who wrote (448)	5/30/1998 6:53:00 PM
From: Marty	Respond to of 705

Dave, I know that the experiences with AIT-082 that were related by this man and that I copied over to the SI board don't prove anything and I hope I said that. It just strikes me that these anecdotes are not without ANY value. Something very good is going on with it even though perhaps the mechanism is not exactly known yet and complete substantiation is still forthcoming. The Canadian trials were tests for toxicity. Nevertheless, the care givers and others in touch with these patients, limited number of them to be sure, can't help but be amazed, touched, impressed, with what they observe. My point is that their experiences are a whole lot better, limited and unqualified with double blind studies as so on as they are, than the mindless posts the skeptics and short sellers have made in their total ignorance of anything in these tests. I never heard those stories about the Canadian patients before. My interest in the company began when I heard a rumor that test results with rats (!) were "spectacular" ... I remember the exact word. Since then I have not had any reason to question any of that and, as far as I know, either has anyone else. In fact, the latest published studies and subsequent tests indicate that it is even better and there are other applications and target markets.